Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.72 |
| ▸ | NPC1 | O15118 | 5/20 | 0.72 |
| ▸ | RAB9A | P51151 | 5/20 | 0.72 |
| ▸ | POLB | P06746 | 3/20 | 0.72 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 9/20 | 0.71 |
| ▸ | HPGD | P15428 | 8/20 | 0.71 |
| ▸ | MAPT | P10636 | 6/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.71 |
| ▸ | TP53 | P04637 | 3/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.71 |
| ▸ | MAOA | P21397 | 2/20 | 0.71 |
| ▸ | MAOB | P27338 | 2/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.71 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.71 |
| ▸ | CA12 | O43570 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31134786 | 1.00 | KDM4E (0.72) | KDM4EALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL29737520 | 1.00 | KDM4E (0.72) | KDM4EALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL232753 | 0.90 | KDM4E (0.74) | KDM4EALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL27869009 | 0.90 | KDM4E (0.68) | KDM4EALDH1A1SMN1; SMN2NPC1RAB9A | |
| SCHEMBL72628 | 0.88 | KDM4E (0.70) | KDM4EALDH1A1SMN1; SMN2NPC1RAB9A | |
| Xenognosin B SCHEMBL72611 | 0.87 | KDM4E (0.83) | KDM4EALDH1A1SMN1; SMN2NPC1RAB9A | |
| Xenognosin B SCHEMBL30851576 | 0.87 | KDM4E (0.83) | KDM4EALDH1A1SMN1; SMN2NPC1RAB9A | |
| 7-Hydroxy Isoflavone SCHEMBL762528 | 0.84 | KDM4E (1.00) | KDM4EALDH1A1SMN1; SMN2NPC1RAB9A | |
| Daidzein SCHEMBL21114371 | 0.83 | KDM4E (1.00) | KDM4EALDH1A1SMN1; SMN2NPC1RAB9A | |
| Daidzein SCHEMBL29374778 | 0.83 | KDM4E (1.00) | KDM4EALDH1A1SMN1; SMN2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | claimed |
| US-20150290271-A1 | Nutraceutical Composition Obtained from Fungus-Challenged Soy Seedlings | FRUTAROM SWITZERLAND LTD. (CH) | 2015-10-15 | — | — | US | claimed |
| EP-2592951-A1 | NUTRACEUTICAL COMPOSITION OBTAINED FROM FUNGUS-CHALLENGED SOY SEEDLINGS | Frutarom Switzerland Ltd (CH) | 2013-05-22 | — | — | EP | claimed |
| WO-2012006750-A1 | NUTRACEUTICAL COMPOSITION OBTAINED FROM FUNGUS-CHALLENGED SOY SEEDLINGS | FRUTAROM SWITZERLAND LTD. (CH) | 2012-01-19 | — | — | WO | claimed |
| US-20020177527-A1 | Methods for the identification of inhibitors of 2'-hydroxyisoflavone reductase expression or activity in plants | ICORIA, INC. | 2002-11-28 | — | — | US | claimed |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | THE BROAD INSTITUTE, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-20250376656-A1 | MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-12-11 | — | — | US | disclosed |
| WO-2025049925-A2 | LIPIDOID COMPOUNDS AND RELATED COMPOSITIONS AND USES | POSEIDA THERAPEUTICS, INC. (US) | 2025-03-06 | — | — | WO | disclosed |
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | disclosed |
| US-12163004-B2 | Polymer composites | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-12-10 | — | — | US | disclosed |
| US-20240355451-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | NESTLE SA (CH) | 2024-10-24 | — | — | US | disclosed |
| EP-4391834-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | Société des Produits Nestlé S.A. (CH) | 2024-07-03 | — | — | EP | disclosed |
| EP-0948602-A1 | RECOMBINANT PINORESINOL/LARICIRESINOL REDUCTASE, RECOMBINANT DIRIGENT PROTEIN, AND METHODS OF USE | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1999-10-13 | — | — | EP | disclosed |
| EP-0866710-A1 | COMPOSITIONS AND METHODS FOR TREATING BONE DEFICIT CONDITIONS | ZymoGenetics, Inc. (US) | 1998-09-30 | — | — | EP | disclosed |
| WO-1998020113-A1 | RECOMBINANT PINORESINOL/LARICIRESINOL REDUCTASE, RECOMBINANT DIRIGENT PROTEIN, AND METHODS OF USE | WASHINGTON STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1998-05-14 | — | — | WO | disclosed |
| US-5750399-A | CONTROL TRANSCRIPTION IN PLANTS | THE SAMUEL ROBERTS NOBLE FOUNDATION, INC. (US) | 1998-05-12 | — | — | US | disclosed |
| EP-0792356-A1 | ISOFLAVONE REDUCTASE PROMOTER | The Samuel Roberts Noble Foundation, Inc. (US) | 1997-09-03 | — | — | EP | disclosed |
| WO-1997015308-A9 | COMPOSITIONS AND METHODS FOR TREATING BONE DEFICIT CONDITIONS | — | 1997-06-26 | — | — | WO | disclosed |
| WO-1997015308-A1 | COMPOSITIONS AND METHODS FOR TREATING BONE DEFICIT CONDITIONS | ZYMOGENETICS, INC. (US) | 1997-05-01 | — | — | WO | disclosed |
| WO-1996015239-A2 | ISOFLAVONE REDUCTASE PROMOTER | THE SAMUEL ROBERTS NOBLE FOUNDATION, INC. (US) | 1996-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | STUB1, SAMM50, CD14 | KDM4E 2737/4885ALDH1A1 1629/4885SMN1; SMN2 4400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.